The hypertension trials

Journal of Hypertension, Supplement

Volumn 14, Issue 2, 1996, Pages

  Sever, Peter S ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Hypertension; Morbidity; Mortality; Trials

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; HUMANS; HYPERTENSION;

EID: 0029904502     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. The Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980, 1:1261-1267.
2. MRC Working Party: Medical Research Council trial of mild hypertension: principal results. BMJ 1985, 291:97-104.
3. Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality In 'mild' hypertension. W EngUMed 1982, 307:976-980.
4. Hypertension Detection and Follow-up Program Cooperative Group: Fiveyear findings of the Hypertension Detection and Follow-up Program. I. Reduction In mortality In persons with high blood pressure. Including mild hypertension. JAMA 1979, 242:2562-2571.
5. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982, 248:1465-1477.